MAP3K8 proto-oncogene activation could trigger the MAPK cascade and regulate the MEK/ERK/JNK, TLR, and IKK/NFKB pathway responses, which not only play decisive roles at different stages of tumor development but also affect immune surveillance and responses to anti-cancer therapy [38,52,53]. The gene discussed is MAP2K7; the disease is cancer.